Trials / Active Not Recruiting
Active Not RecruitingNCT06655870
A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants
A Phase 1, Single-Center, Open-label, Single Ascending Dose and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of mRNA-0184 Administered Subcutaneously in Healthy Participants
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- ModernaTX, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to test the safety of mRNA-0184 in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mRNA-0184 | SC injection |
Timeline
- Start date
- 2024-10-31
- Primary completion
- 2026-06-23
- Completion
- 2026-06-23
- First posted
- 2024-10-23
- Last updated
- 2026-01-20
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06655870. Inclusion in this directory is not an endorsement.